Study: ISET Detects CTCs for Early Diagnosis of Lung Cancer
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read MorePosted by Steve Halasey | Nov 4, 2014 | Research, Respiratory Disease |
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read MorePosted by Jenny Lower | Oct 27, 2014 | Cancer, Colorectal, Lung Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Vela Diagnostics, Singapore, has announced the availability of the Sentosa SQ Non-Small Cell Lung Cancer panel and the Sentosa Colorectal Cancer panel for next-generation sequencing-based detection of sequence variants, for research use only by early-access customers.
Read MorePosted by Steve Halasey | Aug 29, 2014 | Research |
A blood test for the early detection of lung cancer will soon be offered through standard clinical channels as well as directly to consumers.
Read MorePosted by Jenny Lower | Mar 18, 2014 | Cancer, Lung Cancer |
The VeriStrat specimen collection and shipping kit from Biodesix, Boulder, Colo, facilitates specimen collection for the noninvasive, blood-based VeriStrat protein diagnostic to help guide therapy decisions for non-small cell lung cancer patients.
Read MorePosted by Steve Halasey | Jan 7, 2014 | Cancer, Lung Cancer, Molecular Diagnostics |
The National Cancer Institute has awarded Insight Genetics a $1.5 million Phase II continuation of its SBIR contract for developing a companion diagnostic to assess patient resistance to therapies for non-small cell lung cancer.
Read More